In this paper, two methods are presented. One involves the separation of calcipotriol, a new synthetic analogue, from two related compounds, specifically cholecalciferol (Vitamin D 3 ) and calcitriol (1,25-dihydroxyvitamin D 3 ). The other involves the isolation and assay of calcipotriol from a topical ointment. The study was performed with reversed-phase high-performance liquid chromatography using an RP18 column and ultraviolet detection. Applying the method of Snyder, a mobile phase mixture containing methanol-acetonitrile-water (67:23:10, v/v) was found which achieved a total separation within 18 min. A mobile phase of methanol-water (80:20, v/v) attained a slower elution of calcipotriol. For isolation and assay of calcipotriol from an ointment (Daivonex), dissolution in chloroform gave the highest recovery (> 98%). The isolation and assay process can be performed within 2 h.
Introduction
Since the identification of the anti-ricketic factor as Vitamin D in 1923, studies on this substance have increased in number (1) . At present, Vitamin D is known for its regulation of calcium absorption, bone mineralization, and prevention of rickets (2) . However, after the coincidental discovery by Japanese researchers of the effect of a Vitamin D 3 product on the improvement of a patient's psoriasis while being treated for osteoporosis, research has been focused on exploring Vitamin D 3 analogues for the treat ment of psoriasis, a disease characterized by hyperproliferation and incomplete differentiation of the epidermis (3) .
In recent years, a new synthetically prepared analogue called calcipotriol has been identified as a topical antipsoriatic agent (3) (4) (5) . It can regulate cell differentiation and proliferation in vitro and suppress lymphocyte activities. These actions of calcipotriol at the cellular level are very similar to calcitriol (1,25-dihydroxyvitamin D 3 , a natural hormone), yet the influence on calcium and bone metabolism is far less (6, 7) . Calcitriol is the most active metabolic product of Vitamin D 3 , a photochemical product of the *Author to whom correspondence should be addressed.
skin formed after exposure of 7-dehydrocholecalciferol to ultra violet (UV) sunlight. However, there is no method described for the separation of these three substances in a mixture. Individual determinations of calcipotriol (8) , calcitriol (9) , and cholecalcif erol (10, 11) are available.
In this study, a separation procedure was developed using reversed-phase high-performance liquid chromatography (RP-HPLC). The mobile phase composition was optimized by applying the Snyder solvent triangle (12) for a mixture containing cal cipotriol, calcitriol, and cholecalciferol. The separation procedure served as an additional control for the presence of related sub stances in the testing of raw material for any of the three Vitamin D 3 compounds. An isolation method for calcipotriol in a com mercially available ointment (Daivonex) (5,13) was explored.
Experimental

Materials
Equipment
RP-HPLC analysis was performed on a LiChroCART 5-μm RP18 4 × 125-mm column (Merck, Darmstadt, Germany), a MerckHitachi L-6000A pump with a Perkin-Elmer LC 90 UV spectrophotometric detector (Norwalk, CT), and a Merck-Hitachi D-2500 integrator. The flow rate was 2 mL/min for separation and 1 mL/min for assay and recovery. The UV detection wavelength was 254 nm for separation and 263 nm for assay and recovery. The loop volume was 20 μL. A GFL Schüttelwasserbad 1083 (GFL mbH, Burgwedel, Germany) at 120 vibrations per minute was used for shaking during the isolation of a mixture containing the ointment and a solvent. All centrifugations were performed using a Mistral 400 refrigerated centrifuge (MSE, West Sussex, England). Spectrophotometric analysis was performed with a Uvikon 860 spectrophotometer (Kontron Instruments AG, Zurich, Switzerland).
Chemicals
Samples of calcipotriol and calcitriol crystals were provided by Schering AG (Berlin, Germany), and calcipotriol in isopropanol was provided by Leo Pharmaceuticals (Ballerup, Denmark). Daivonex 50-μg/g ointment was manufactured by Leo Phar maceuticals (Denmark). Cholecalciferol was purchased from Sigma-Aldrich (Bornem, Belgium). Chloroform and methanol were purchased from Merck. Acetonitrile for HPLC was pur chased from CRB (Brussels, Belgium). Milli-Q water was purified using Seralpur Pro 90CN filters (Merck-Belgolabo, Overijse, Belgium). All solutions were prepared under red light at ambient temperature. Solutions were kept in amber-colored bottles wrapped in aluminum foil and stored at -5°C until use. Prior to and during HPLC analysis, samples were stored in a refrigerator at 8-15°C.
Methods and solutions
Separation and assay of calcipotriol
Stock solutions containing 100 μg/mL of the individual sub stances were prepared by dissolving the necessary amounts in methanol, which were then diluted further in methanol-water (80:20, v/v) to make 10-μg/mL solutions for injection.
Determination of calcipotriol in the ointment
One gram of the ointment containing 50 μg calcipotriol was dissolved in 10 mL chloroform, shaken for 1 h, then centrifuged at a relative centrifugal force of 1562 × g for 10 min at -5°C. One milliliter of the clear portion was pipetted out and diluted 2.5 times with methanol to make a theoretical concentration of 2 μg/mL. This solution was again centrifuged under the same con ditions, after which 1 mL of the clear portion was pipetted out and diluted with the mobile phase (methanol-water, 80:20, v/v) to make theoretical concentrations of 500 ng/mL and 1 μg/mL.
Recovery
The recovery was computed as the peak area of calcipotriol from the ointment divided by the corresponding peak area of a reference solution (standard) containing calcipotriol at one of two possible concentrations (e.g., 500 ng/mL or 1 μg/mL) in chloro form.
Limit of detection and quantitation
A 100-μg/mL stock solution of calcipotriol was prepared by dis solving the necessary amounts in methanol. A working solution of 500 ng/mL and additional dilutions from 100 to 10 ng/mL were made in the mobile phase (methanol-water, 80:20, v/v).
Results and Discussion
Since there are two related compounds for the analogue of interest, the study began with a search for a mobile phase able to Figure 1 ). The varying levels of toxicity between the natural hormone calcitriol (metabolic byproduct of cholecalciferol) and the synthetically prepared Vitamin D 3 ana logue calcipotriol are attributed to the fact that calcipotriol exhibits over 100 times less hypercalcemic effect (4,7) than cal citriol.
Separation of Calcipotriol from related compounds
Using Snyder's solvent classification scheme (12), a search for a good mobile phase composition was started, monitoring at 254 nm with an initial flow rate of 1 mL/min. Because detection at a fixed wavelength of 254 nm is commonly used, this wavelength was arbitrarily chosen in the beginning of our experiments to be the detection wavelength for the separation. The mobile phase optimization began with methanol as the selectivity solvent. Methanol was chosen because of previous data (unpublished) where the retention time of cholecalciferol was 4.5-4.7 min with pure methanol as mobile phase. However results showed that with pure methanol (solvent strength 2.6), undesirable capacity factor (k ) values of 0.05 and 0.14 were obtained for calcipotriol and calcitriol, respectively, while cholecalciferol achieved a k value of 2.97 (Table I) . Several mobile phase mixtures were tried in an attempt to increase the capacity factors of calcipotriol and calcitriol while maintaining the solvent strength of the mixture. A mobile phase with two organic modifiers, methanol and ace tonitrile, already gave better results but was not acceptable, because the k of calcipotriol was less than 1. However, when the mobile phase composition was changed to methanol-acetonitrile-water (67:23:10, v/v) while maintaining the solvent strength at 2.4, the capacity factors for the three components all became larger than 1. The retention time of cholecalciferol was consid ered quite long at 35.20 min (k = 34.92). The necessity of where Rs is the resolution, a is the separation factor, Ν is the number of theoretical plates, and k is the capacity factor. It is shown that Rs is proportional to k /(l + k ); therefore, increases in k > 10 will have a very small effect on the resolution in compar ison to those increases in the range of 1-10 (14) . A k range of 1-10 for all components of the sample is desirable but may be extended, depending upon separation complexity (15) . By increasing the flow rate to 2 mL/min, a total running time of less than 18 min was achieved. The elution times of calcipotriol and calcitriol are relatively close, as can be noted but are still well sep arated from the injection peak, with k = 1.12 and 1.86, respec tively, and an Rs value of 1.27 between the analogues (Figure 2 ). It should be remembered that the aim of our experimental setup was to obtain a separation between calcipotriol and two of its related products, not necessarily to have a method able to quantitate all three substances. Therefore, we chose to use an isocratic method, if possible, with an acceptable run time. We considered the final results presented in Figure 2 acceptable for that purpose, and for that reason no further attempts were made to optimize a gradient method. Also, it was feared that the analysis time of such a method would not be shorter, taking into account both the run time and the time to reequilibrate the column in a gradient method.
Assay of Calcipotriol
With calcipotriol as the substance of interest and its elution close to the injection peak using a mobile phase containing methanol-acetonitrile-water (67:23:10, v/v), a new search was initiated to find a mobile phase that gave an elution further from the injection peak. Since quantitative analysis was to be con ducted, UV detection was now monitored at 263 nm, based on a 
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acquiring a k value greater than 1 is explained in the following equation for the resolution of peaks (14): Eq 1 spectrophotometric analysis of calcipotriol. The mobile phase containing methanol-water (80:20, v/v, solvent strength 2.08) gave a k' value of 5.43, and thus no further search was conducted (Figure 3 ). Using this mobile phase, a parallel study was con ducted to see if a better separation between the closely eluting analogues was also achieved. Results showed a good separation for calcipotriol and calcitriol with respective k values of 5.43 and 10.32 and a resolution of 2.95. However, the mobile phase with the binary mixture of methanol-water (80:20, v/v) can only be used when cholecalciferol does not appear in a given sample; oth erwise, it is advisable to use the ternary mixture of methanolacetonitrile-water (67:23:10, v/v) described earlier.
Limit of detection and limit of quantitation
With a very low therapeutic dose for calcipotriol (5), and a rela tively high risk of hypercalcemia if the recommended dose is not adhered to (16) , another important aspect of the chromato graphic process was studied: the sensitivity of detection. The rel ative sample sensitivity of a detector is defined as the minimum concentration of solute which can be detected and is evaluated by using the signal-to-noise (S/N) ratio. The S/N ratio can be calcu lated for the equation (17): Eq2 where Η is the height of the peak of interest (calcipotriol) and hn is the absolute value of the longest noise amplitude fluctuation from the baseline in a chromatogram obtained after injection of a blank solution, observed over a distance equal to 20 times the width at half height of a calcipotriol peak, and situated equally around the retention time of this calcipotriol peak.
Limit of detection
The limit of detection (LOD) was evaluated by six injections of a 10-ng/mL solution of reference calcipotriol at a preferred detec- tion wavelength of 263 nm and a flow rate of 1 mL/min. The S/N ratio was 3.2. Results showed that calcipotriol can be easily detected, but the peak areas obtained were variable. The percent relative standard deviation was 3.71 (Table II) .
Limit of quantitation
The limit of quantitation (LOQ) was investigated by injecting 20 ng/mL calcipotriol. Six injections were performed and detected under the same conditions as LOD. With a S/N ratio of 4.8 and percent relative standard deviation of 2.10, the solution with 20 ng was considered the LOQ.
Linearity
The linear dynamic range, which is the number of times the sample concentration can be increased from the LOQ to the con centration at which the detector is no longer linearly proportional to the sample concentration, was studied. The relationship obtained between peak area and amount of calcipotriol injected is linear from the selected range of 20-100 ng/mL with a correlation coefficient of 0.9994. To verify the prediction capability, three concentrations of 25, 50, and 75 ng/mL situated in the linear dynamic range and within the standards to construct the calibra tion line were selected and injected. Results showed that the per cent deviation of the peak areas obtained from the three prediction concentrations were ± 4% (Table III) .
Determination of calcipotriol in a pharmaceutical preparation
The selection of solvent for the isolation of calcipotriol from its pharmaceutical preparation was based on finding the solvent which could dissolve most of the ingredients from the ointment (particularly calcipotriol). The principle behind the selection was to dissolve as much calcipotriol in the fatty fraction of the oint ment as possible. Several solvents were tested by dissolving 1 g of ointment in 10 mL of solvent and shaking for 1 h. Solvents tested were methanol, ethanol, isopropanol, acetonitrile, and chloro form. The results showed that chloroform liquified the ointment while other solvents did not, even after prolonged shaking. Based on this observation, chloroform was selected to be the solvent of choice. The mixture produced after shaking was turbid and was therefore centrifuged at -5°C in order to separate the solidified fats and insolubles. The turbidity was caused by the presence of polyoxyethylene-2-stearyl ether, which is insoluble in chloroform and occurs in the ointment base. An intermediate step with methanol was necessary in order to avoid solubility problems between chloroform and the mobile phase. The mobile phase which was used as the final diluting solvent contained 80% methanol and 20% water. No separation in two mixtures (layers) was observed after the sample diluted with methanol was further diluted with the mobile phase. However, the solu tion became slightly turbid. This turbidity was caused by the insolubility of remaining fats in the aqueous solvent. No additional attempt was made to remove these fats, because calcipotriol is lypophilic and may be affected. The turbid solu tion was directly injected onto the column. No dis turbances of the chromatograms by fats were observed. In order to minimize an occasional cumulative effect of these fats on the performance, the column was rinsed with methanol for 30 min after turning the column to wash away the fats occasionally retained on the column. It was noted that the recovery was greater than 98%, so the cleaning regime administered to the column was efficient (or the fats did not cause any problems).
Recovery
The samples obtained from the determination of calcipotriol in the ointment were diluted for injection (using the same dilution scheme) to theoretical concentrations of 500 and 1000 ng/mL. The calcipotriol concentrations obtained from the ointment were compared to the peak areas obtained from reference solutions of calcipotriol (i.e., 500 ng/mL and 1 μg/mL). Tests for repeatability of injections and dilutions for both samples and standards at the two concentrations showed an overall relative standard deviation of less than 2%. When the peak areas obtained from the sample were superimposed on the peak areas of the reference, there were respective overlaps denoting high recovery. The recovery from six separate determinations in both concentrations were found to be greater than 98%. The complete procedure from isolation to recovery can be performed within 2 h.
Conclusion
The separation procedure for calcipotriol, calcitriol, and chole calciferol can be used routinely as an additional control for the presence of related substances in the testing of raw material for any of the three Vitamin D 3 compounds. The simple assay proce dure for calcipotriol can be used to detect its presence in samples, even at very low concentrations. The isolation and recovery can be performed within a couple of hours. These various methods described are simple, sensitive, repeatable, and can be used on a daily basis as part of routine analysis.
